Selective regulation of aspartyl intramembrane protease activity by calnexin.


Journal

Cellular and molecular life sciences : CMLS
ISSN: 1420-9071
Titre abrégé: Cell Mol Life Sci
Pays: Switzerland
ID NLM: 9705402

Informations de publication

Date de publication:
26 Oct 2024
Historique:
received: 12 06 2024
accepted: 11 10 2024
revised: 09 09 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 26 10 2024
Statut: epublish

Résumé

Signal peptide peptidase-like 2c (SPPL2c) is a testis-specific aspartyl intramembrane protease that contributes to male gamete function both by catalytic and non-proteolytic mechanisms. Here, we provide an unbiased characterisation of the in vivo interactome of SPPL2c identifying the ER chaperone calnexin as novel binding partner of this enzyme. Recruitment of calnexin specifically required the N-glycosylation within the N-terminal protease-associated domain of SPPL2c. Importantly, mutation of the single glycosylation site of SPPL2c or loss of calnexin expression completely prevented SPPL2c-mediated intramembrane proteolysis of all tested substrates. By contrast and despite rather promiscuous binding of calnexin to other SPP/SPPL proteases, expression of the chaperone was exclusively required for SPPL2c-mediated proteolysis. Despite some impact on the stability of SPPL2c most presumably due to assistance in folding of the luminal domain of the protease, calnexin appeared to be recruited rather constitutively to the protease thereby boosting its catalytic activity. In summary, we describe a novel, highly specific mode of intramembrane protease regulation, highlighting the need to systematically approach control mechanisms governing the proteolytic activity of other members of the aspartyl intramembrane protease family.

Identifiants

pubmed: 39460794
doi: 10.1007/s00018-024-05478-8
pii: 10.1007/s00018-024-05478-8
doi:

Substances chimiques

Calnexin 139873-08-8
Aspartic Acid Endopeptidases EC 3.4.23.-
Aspartic Acid Proteases EC 3.4.-
signal peptide peptidase EC 3.4.23.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

441

Informations de copyright

© 2024. The Author(s).

Références

Voss M, Schröder B, Fluhrer R (2013) Mechanism, specificity, and physiology of signal peptide peptidase (SPP) and SPP-like proteases. Biochim Biophys Acta 1828(12):2828–2839. https://doi.org/10.1016/j.bbamem.2013.03.033
doi: 10.1016/j.bbamem.2013.03.033 pubmed: 24099004
Truberg J, Hobohm L, Jochimsen A et al (2022) Endogenous tagging reveals a mid-golgi localization of the glycosyltransferase-cleaving intramembrane protease SPPL3. Biochimica et biophysica acta. Mol cell Res 1869(11):119345. https://doi.org/10.1016/j.bbamcr.2022.119345
doi: 10.1016/j.bbamcr.2022.119345
Behnke J, Schneppenheim J, Koch-Nolte F et al (2011) Signal-peptide-peptidase-like 2a (SPPL2a) is targeted to lysosomes/late endosomes by a tyrosine motif in its C-terminal tail. FEBS Lett 585(19):2951–2957. https://doi.org/10.1016/j.febslet.2011.08.043
doi: 10.1016/j.febslet.2011.08.043 pubmed: 21896273
Friedmann E, Lemberg MK, Weihofen A et al (2004) Consensus analysis of signal peptide peptidase and homologous human aspartic proteases reveals opposite topology of catalytic domains compared with presenilins. J Biol Chem 279(49):50790–50798. https://doi.org/10.1074/jbc.M407898200
doi: 10.1074/jbc.M407898200 pubmed: 15385547
Niemeyer J, Mentrup T, Heidasch R et al (2019) The intramembrane protease SPPL2c promotes male germ cell development by cleaving phospholamban. EMBO Rep 20(3). https://doi.org/10.15252/embr.201846449
Weihofen A, Binns K, Lemberg MK et al (2002) Identification of signal peptide peptidase, a presenilin-type aspartic protease. Science 296(5576):2215–2218. https://doi.org/10.1126/science.1070925
doi: 10.1126/science.1070925 pubmed: 12077416
Hsu FF, Yeh CT, Sun YJ et al (2015) Signal peptide peptidase-mediated nuclear localization of heme oxygenase-1 promotes cancer cell proliferation and invasion independent of its enzymatic activity. Oncogene 34(18):2410–2411. https://doi.org/10.1038/onc.2014.464
doi: 10.1038/onc.2014.464 pubmed: 25924715
Hsu FF, Chou YT, Chiang MT et al (2019) Signal peptide peptidase promotes tumor progression via facilitating FKBP8 degradation. Oncogene 38(10):1688–1701. https://doi.org/10.1038/s41388-018-0539-y
doi: 10.1038/s41388-018-0539-y pubmed: 30348988
Chen CY, Malchus NS, Hehn B et al (2014) Signal peptide peptidase functions in ERAD to cleave the unfolded protein response regulator XBP1u. EMBO J 33(21):2492–2506. https://doi.org/10.15252/embj.201488208
doi: 10.15252/embj.201488208 pubmed: 25239945 pmcid: 4283407
Avci D, Heidasch R, Costa M et al (2024) Intramembrane protease SPP defines a cholesterol-regulated abundance control of the mevalonate pathway enzyme squalene synthase. J Biol Chem 300(2):105644. https://doi.org/10.1016/j.jbc.2024.105644
doi: 10.1016/j.jbc.2024.105644 pubmed: 38218226 pmcid: 10850959
McLauchlan J, Lemberg MK, Hope G et al (2002) Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J 21(15):3980–3988. https://doi.org/10.1093/emboj/cdf414
doi: 10.1093/emboj/cdf414 pubmed: 12145199 pmcid: 126158
Voss M, Künzel U, Higel F et al (2014) Shedding of glycan-modifying enzymes by signal peptide peptidase-like 3 (SPPL3) regulates cellular N-glycosylation. EMBO J 33(24):2890–2905. https://doi.org/10.15252/embj.201488375
doi: 10.15252/embj.201488375 pubmed: 25354954 pmcid: 4282638
Schneppenheim J, Dressel R, Huttl S et al (2013) The intramembrane protease SPPL2a promotes B cell development and controls endosomal traffic by cleavage of the invariant chain. J Exp Med 210(1):41–58. https://doi.org/10.1084/jem.20121069
doi: 10.1084/jem.20121069 pubmed: 23267015 pmcid: 3549707
Gradtke A-C, Mentrup T, Lehmann CHK et al (2021) Deficiency of the intramembrane protease SPPL2a alters antimycobacterial cytokine responses of dendritic cells. J Immunol (Baltimore Md : 1950) 206(1):164–180. https://doi.org/10.4049/jimmunol.2000151
doi: 10.4049/jimmunol.2000151
Mentrup T, Stumpff-Niggemann AY, Leinung N et al (2022) Phagosomal signalling of the C-type lectin receptor Dectin-1 is terminated by intramembrane proteolysis. Nat Commun 13(1):1880. https://doi.org/10.1038/s41467-022-29474-3
doi: 10.1038/s41467-022-29474-3 pubmed: 35388002 pmcid: 8987071
Mentrup T, Theodorou K, Cabrera-Cabrera F et al (2019) Atherogenic LOX-1 signaling is controlled by SPPL2-mediated intramembrane proteolysis. J Exp Med 216(4):807–830. https://doi.org/10.1084/jem.20171438
doi: 10.1084/jem.20171438 pubmed: 30819724 pmcid: 6446863
Papadopoulou AA, Muller SA, Mentrup T et al (2019) Signal peptide peptidase-like 2c (SPPL2c) impairs vesicular transport and cleavage of SNARE proteins. EMBO Rep 20(3). https://doi.org/10.15252/embr.201846451
Brown MS, Ye J, Rawson RB et al (2000) Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100(4):391–398
doi: 10.1016/S0092-8674(00)80675-3 pubmed: 10693756
Ballin M, Griep W, Patel M et al (2022) The intramembrane proteases SPPL2a and SPPL2b regulate the homeostasis of selected SNARE proteins. FEBS J. https://doi.org/10.1111/febs.16610
doi: 10.1111/febs.16610 pubmed: 36047592
Boname JM, Bloor S, Wandel MP et al (2014) Cleavage by signal peptide peptidase is required for the degradation of selected tail-anchored proteins. J Cell Biol 205(6):847–862. https://doi.org/10.1083/jcb.201312009
doi: 10.1083/jcb.201312009 pubmed: 24958774 pmcid: 4068138
Contreras W, Wiesehöfer C, Schreier D et al (2022) C11orf94/Frey is a key regulator for male fertility by controlling Izumo1 complex assembly. Sci Adv 8(32):eabo6049. https://doi.org/10.1126/sciadv.abo6049
doi: 10.1126/sciadv.abo6049 pubmed: 35960805 pmcid: 9374335
Contreras W, Bazan JF, Mentrup T (2023) The transmembrane domain of Frey1 harbors a transplantable inhibitory motif for intramembrane proteases. Cell Mol Life Sci 80(6):170. https://doi.org/10.1007/s00018-023-04823-7
doi: 10.1007/s00018-023-04823-7 pubmed: 37261541 pmcid: 10234869
Hao H, Shi B, Zhang J et al (2022) The vertebrate- and testis- specific transmembrane protein C11ORF94 plays a critical role in sperm-oocyte membrane binding. Mol Biomed 3(1):27. https://doi.org/10.1186/s43556-022-00092-1
doi: 10.1186/s43556-022-00092-1 pubmed: 36050562 pmcid: 9437168
Lu Y, Shimada K, Tang S et al (2023) 1700029I15Rik orchestrates the biosynthesis of acrosomal membrane proteins required for sperm-egg interaction. PNAS 120(8):e2207263120. https://doi.org/10.1073/pnas.2207263120
doi: 10.1073/pnas.2207263120 pubmed: 36787362 pmcid: 9974436
Kraus A, Groenendyk J, Bedard K et al (2010) Calnexin deficiency leads to dysmyelination. J Biol Chem 285(24):18928–18938. https://doi.org/10.1074/jbc.M110.107201
doi: 10.1074/jbc.M110.107201 pubmed: 20400506 pmcid: 2881815
Schneppenheim J, Hüttl S, Mentrup T et al (2014) The intramembrane proteases signal peptide peptidase-like 2a and 2b have distinct functions in vivo. Mol Cell Biol 34(8):1398–1411. https://doi.org/10.1128/MCB.00038-14
doi: 10.1128/MCB.00038-14 pubmed: 24492962 pmcid: 3993588
Paskevicius T, Farraj RA, Michalak M et al (2023) Calnexin, more Than just a molecular chaperone. Cells 12(3). https://doi.org/10.3390/cells12030403
Bloemeke N, Meighen-Berger K, Hitzenberger M et al (2022) Intramembrane client recognition potentiates the chaperone functions of calnexin. EMBO J 41(24):e110959. https://doi.org/10.15252/embj.2022110959
doi: 10.15252/embj.2022110959 pubmed: 36314723 pmcid: 9753464
Ikawa M, Wada I, Kominami K et al (1997) The putative chaperone calmegin is required for sperm fertility. Nature 387(6633):607–611. https://doi.org/10.1038/42484
doi: 10.1038/42484 pubmed: 9177349
Ikawa M, Nakanishi T, Yamada S et al (2001) Calmegin is required for fertilin alpha/beta heterodimerization and sperm fertility. Dev Biol 240(1):254–261. https://doi.org/10.1006/dbio.2001.0462
doi: 10.1006/dbio.2001.0462 pubmed: 11784061
Yamagata K, Nakanishi T, Ikawa M et al (2002) Sperm from the calmegin-deficient mouse have normal abilities for binding and fusion to the egg plasma membrane. Dev Biol 250(2):348–357
doi: 10.1006/dbio.2002.0803 pubmed: 12376108
Höppner S, Schröder B, Fluhrer R (2023) Structure and function of SPP/SPPL proteases: insights from biochemical evidence and predictive modeling. FEBS J. https://doi.org/10.1111/febs.16968
doi: 10.1111/febs.16968 pubmed: 37786993
Leinung N, Mentrup T, Patel M et al (2023) Dynamic association of the intramembrane proteases SPPL2a/b and their substrates with tetraspanin-enriched microdomains. iScience 26(10):107819. https://doi.org/10.1016/j.isci.2023.107819
doi: 10.1016/j.isci.2023.107819 pubmed: 37736044 pmcid: 10509304
Fluhrer R, Grammer G, Israel L et al (2006) A gamma-secretase-like intramembrane cleavage of TNFalpha by the GxGD aspartyl protease SPPL2b. Nat Cell Biol 8(8):894–896. https://doi.org/10.1038/ncb1450
doi: 10.1038/ncb1450 pubmed: 16829951
Kimberly WT, LaVoie MJ, Ostaszewski BL et al (2003) Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc Natl Acad Sci U S A 100(11):6382–6387. https://doi.org/10.1073/pnas.1037392100
doi: 10.1073/pnas.1037392100 pubmed: 12740439 pmcid: 164455
Capell A, Beher D, Prokop S et al (2005) Gamma-secretase complex assembly within the early secretory pathway. J Biol Chem 280(8):6471–6478. https://doi.org/10.1074/jbc.M409106200
doi: 10.1074/jbc.M409106200 pubmed: 15591316
Fassler M, Zocher M, Klare S et al (2010) Masking of transmembrane-based retention signals controls ER export of gamma-secretase. Traffic 11(2):250–258. https://doi.org/10.1111/j.1600-0854.2009.01014.x
doi: 10.1111/j.1600-0854.2009.01014.x pubmed: 19958468
Kozlov G, Gehring K (2020) Calnexin cycle - structural features of the ER chaperone system. FEBS J 287(20):4322–4340. https://doi.org/10.1111/febs.15330
doi: 10.1111/febs.15330 pubmed: 32285592 pmcid: 7687155
Zapun A, Petrescu SM, Rudd PM et al (1997) Conformation-independent binding of monoglucosylated ribonuclease B to calnexin. Cell 88(1):29–38. https://doi.org/10.1016/s0092-8674(00)81855-3
doi: 10.1016/s0092-8674(00)81855-3 pubmed: 9019402
Ou WJ, Cameron PH, Thomas DY et al (1993) Association of folding intermediates of glycoproteins with calnexin during protein maturation. Nature 364(6440):771–776. https://doi.org/10.1038/364771a0
doi: 10.1038/364771a0 pubmed: 8102790
Sakono M, Seko A, Takeda Y et al (2014) Glycan specificity of a testis-specific lectin chaperone calmegin and effects of hydrophobic interactions. Biochim Biophys Acta 1840(9):2904–2913. https://doi.org/10.1016/j.bbagen.2014.04.012
doi: 10.1016/j.bbagen.2014.04.012 pubmed: 24769397
Yamaguchi R, Yamagata K, Ikawa M et al (2006) Aberrant distribution of ADAM3 in sperm from both angiotensin-converting enzyme (Ace)- and calmegin (Clgn)-deficient mice. Biol Reprod 75(5):760–766. https://doi.org/10.1095/biolreprod.106.052977
doi: 10.1095/biolreprod.106.052977 pubmed: 16870943
Inoue N, Hamada D, Kamikubo H et al (2013) Molecular dissection of IZUMO1, a sperm protein essential for sperm-egg fusion. Development 140(15):3221–3229. https://doi.org/10.1242/dev.094854
doi: 10.1242/dev.094854 pubmed: 23824580
Barbaux S, Ialy-Radio C, Chalbi M et al (2020) Sperm SPACA6 protein is required for mammalian sperm-Egg Adhesion/Fusion. Sci Rep 10(1):5335. https://doi.org/10.1038/s41598-020-62091-y
doi: 10.1038/s41598-020-62091-y pubmed: 32210282 pmcid: 7093486
Noda T, Lu Y, Fujihara Y et al (2020) Sperm proteins SOF1, TMEM95, and SPACA6 are required for sperm-oocyte fusion in mice. PNAS 117(21):11493–11502. https://doi.org/10.1073/pnas.1922650117
doi: 10.1073/pnas.1922650117 pubmed: 32393636 pmcid: 7261011
Rahmani M, Tavalaee M, R Drevet J et al (2023) Role of endoplasmic reticulum stress in the male Reproductive System. Cell J 25(7):437–446. https://doi.org/10.22074/CELLJ.2023.1983074.1205
doi: 10.22074/CELLJ.2023.1983074.1205 pubmed: 37543856 pmcid: 10404359
Yu R, Chen X, Zhu X et al (2022) ATF6 deficiency damages the development of spermatogenesis in male Atf6 knockout mice. Andrologia 54(3):e14350. https://doi.org/10.1111/and.14350
doi: 10.1111/and.14350 pubmed: 34904262
Inoue N, Hagihara Y, Wada I (2021) Evolutionarily conserved sperm factors, DCST1 and DCST2, are required for gamete fusion. eLife 10. https://doi.org/10.7554/eLife.66313
Perez-Riverol Y, Csordas A, Bai J et al (2019) The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res 47(D1):D442–D450. https://doi.org/10.1093/nar/gky1106
doi: 10.1093/nar/gky1106 pubmed: 30395289
Deutsch EW, Bandeira N, Sharma V et al (2020) The ProteomeXchange consortium in 2020: enabling ‘big data’ approaches in proteomics. Nucleic Acids Res 48(D1):D1145–D1152. https://doi.org/10.1093/nar/gkz984
doi: 10.1093/nar/gkz984 pubmed: 31686107

Auteurs

Whendy Contreras (W)

Institute of Physiological Chemistry, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Jody Groenendyk (J)

Department of Biochemistry, University of Alberta, Edmonton, AB, T6G 2H7, Canada.

Marc Gentzel (M)

Core Facility Molecular Analysis - Mass Spectrometry, Mass Spectrometry & Proteomics, Center for Molecular and Cellular Bioengineering (CMCB), Technische Universität Dresden, Dresden, Germany.

Pascal Y Schönberg (PY)

Medical Faculty, University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, 01307, Dresden, Germany.

Frank Buchholz (F)

Medical Faculty, University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, 01307, Dresden, Germany.

Marek Michalak (M)

Department of Biochemistry, University of Alberta, Edmonton, AB, T6G 2H7, Canada.

Bernd Schröder (B)

Institute of Physiological Chemistry, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Torben Mentrup (T)

Institute of Physiological Chemistry, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. torben.mentrup@tu-dresden.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH